MB21 is an inhibitor of dengue type 2 protease. It acts by inhibiting each one of the four serotypes of dengue viruses in infected cells in culture. References: Mirza SB, Lee RCH, Chu JJH, Salmas RE, Mavromoustakos T, Durdagi S. Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies. J Mol Graph Model. 2018 Jan;79:88-102. doi: 10.1016/j.jmgm.2017.10.010. Epub 2017 Oct 24. PubMed PMID: 29156382.

纯度：≥98%

CAS：1870007-38-7